{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Cytostatic and anti - angiogenic effects of temsirolimus in refractory mantle cell lymphoma .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| cytostatic and anti-angiogenic effects |\n| temsirolimus |\n| refractory mantle cell lymphoma |\n\nExplanation:\n\n* \"Cytostatic and anti-angiogenic effects\" are effects that can be associated with a disease or treatment.\n* \"Temsirolimus\" is a medication that is often used to treat certain types of cancer, so it can be considered a disease entity in this context.\n* \"Refractory mantle cell lymphoma\" is a specific type of cancer, so it is also a disease entity."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| refractory mantle cell lymphoma |\n\nExplanation:\n\n* \"Cytostatic and anti-angiogenic effects\" are not diseases, but rather effects that can be associated with a disease or treatment.\n* \"Temsirolimus\" is a medication used to treat certain types of cancer, but it is not a disease itself.\n* \"Refractory mantle cell lymphoma\" is a specific type of cancer, so it is the only clear disease entity in the paragraph."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Cytostatic and anti - angiogenic effects of temsirolimus in refractory mantle cell lymphoma .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temsirolimus |\n\nExplanation:\n\nIn the given paragraph, the only chemical entity mentioned is \"temsirolimus.\" It is a medication used to treat certain types of cancer. Therefore, the resulting Markdown table contains one row with the chemical name \"temsirolimus\" in the \"Chemical\" column."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temsirolimus |\n\nExplanation:\n\nIn the given paragraph, the only unambiguous chemical entity mentioned is \"temsirolimus.\" The term \"cytostatic\" refers to a property or effect of certain chemicals (in this case, temsirolimus) that inhibit or prevent the growth and multiplication of cells, particularly cancer cells. Similarly, \"anti-angiogenic\" describes the ability of certain chemicals to prevent the growth of new blood vessels, which can be a desired effect in cancer treatment. However, these terms are not specific chemical names themselves, so they are not included in the table."}
  ]
}